Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $1.06 per share versus the Zacks Consensus Estimate of a loss of$1.35. This compares to loss of $1.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 21.48$1.47 per share when it actually produced a loss of $1.46, delivering a surprise of 0.68%. Over the last four quarters, the company ...